-
Two oral medications for relapsing-remitting MS in phase III development; antihypertensives find new uses; Ginkgo biloba does not prevent cognitive decline in elderly; and FDA Actions.
-
-
Among 300 women treated at MD Anderson with radiation therapy for cervical cancer, pelvic fracture occurred in 29, with 83% diagnosed within two years of completing therapy. Older age and lower BMI were found to be significant risk factors.
-
Myeloma patients with symptoms caused by the disease (i.e., anemia, lytic bone lesions, hypercalcemia, renal insufficiency, extramedullary plasmacytoma) require treatment with chemotherapy.
-
-
The American College of Obstetricians and Gynecologists (ACOG) has published a new review of data supporting the noncontraceptive uses of hormonal contraceptives to treat specific conditions.
-
What is your facility's protocol when it comes to testing for sexually transmitted diseases (STDs)? It probably involves patient testing, with treatment provided after test results are completed.
-
The options in birth control might be set to expand: Watson Pharmaceuticals of Corona, CA, has signed an exclusive licensing agreement to commercialize the Population Council's investigational contraceptive vaginal ring in the United States, Canada, and Mexico.
-
-
Learn to be more specific in your sexual health history taking. Results of a new study from the Kinsey Institute for Research in Sex, Gender and Reproduction at Indiana University in Bloomington indicate that no uniform consensus exists when the term "had sex" is used.